ACM
VYGR icon

Aquatic Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Aquatic Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,300
Closed -$101K – 1642
2024
Q3 		$101K Sell
17,300
-4,000
-19% -$29.1K ﹤0.01% 924
2024
Q2 		$168K Buy
+21,300
New +$179K 0.01% 790
2024
Q1 		– Sell
-1,100
Closed -$9K – 1687
2023
Q4 		$9K Buy
+1,100
New +$7.98K ﹤0.01% 1266
2022
Q4 		– Sell
-2,300
Closed -$14K – 1869
2022
Q3 		$14K Buy
2,300
+2,100
+1,050% +$13.4K ﹤0.01% 1034
2022
Q2 		$1K Buy
+200
New +$1.35K ﹤0.01% 1136

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aquatic Capital Management's VYGR Position: Q4 2024 in Review

Aquatic Capital Management sold out of Voyager Therapeutics (VYGR) in Q4 2024, closing a stake of 17,300 shares — an estimated $101K sold.

Aquatic Capital Management first reported a position in VYGR in Q2 2022 and held it in 5 quarters. The position peaked at $168K in Q2 2024. 132 funds tracked by Wall St. Rank hold VYGR as of Q4 2024.

  • Aquatic Capital Management reported no remaining Voyager Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Aquatic Capital Management sold 17,300 Voyager Therapeutics shares in Q4 2024, an estimated $101K.
  • Aquatic Capital Management first reported a position in Voyager Therapeutics in Q2 2022 and held it in 5 quarters.
  • Aquatic Capital Management's Voyager Therapeutics position peaked at $168K in Q2 2024.
  • 132 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2024.

Based on Aquatic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.